Psychosocial Complexity Does Not Predict Withdrawal During Methadone-Buprenorphine Transfer
This cohort challenges the practice of screening out complex patients from methadone-to-buprenorphine transfer, showing withdrawal follows a predictable trajectory independent of psychosocial risk factors.
📅 Journal publication: Jul 2026·Last updated: Aug 5, 2026
buprenorphinemethadoneopioid agonist therapyopioid use disordermethadone-buprenorphine transferprecipitated withdrawalCOWSSOWSprospective cohortlow-dose inductionstop-and-startBehavioral Health / Addiction Medicine
Background Information
Withdrawal during methadone-to-buprenorphine transfers peaks and is predictable.
Understanding withdrawal experiences during methadone-to-buprenorphine transfers (MBT) can improve the management and support for patients in opioid agonist therapy. Withdrawal peaked around Day 5 and was not influenced by psychosocial factors. Low-dose transfer delayed peak withdrawal by 2.3 days and increased the severity slightly compared to stop-and-start methods. These results suggest that clinicians should plan for expected withdrawal without selecting patients based on perceived psychosocial complexity during MBT. Withdrawal during MBT is predictable, allowing strategic planning for patient support.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Tremonti C, Mills L, Lintzeris N, Blogg J, Jamshidi N, Harjanto R, Blazey A, Montebello M, Ismay C, Page R, Buckley NA, Perananthan V, Haber PS
Citation:Tremonti C, Mills L, Lintzeris N, et al. Patient Experience of Withdrawal During Methadone-Buprenorphine Transfer: A Prospective Cohort Study. Drug and alcohol review. 2026;45(5):e70211. doi:10.1111/dar.70211